Long‐term follow‐up of chronic central serous chorioretinopathy patients receiving oral eplerenone and half‐dose photodynamic therapy in the SPECTRA trial: SPECTRA trial report No. 4
This study provides evidence for the long-term efficacy of half-dose PDT in resolving SRF and improving functional outcomes in cCSC. Even when patients initially received eplerenone treatment that did not result in complete SRF resolution, crossover treatment with half-dose PDT led to similar (long-term) group outcomes compared to half-dose PDT as initial treatment.
Authors
- Issam el Mansori
- Roula Tsonaka
- Roselie M. H. Diederen
- Helena M. A. Feenstra
- Thomas J. van Rijssen
- Camiel J. F. Boon
- Carel B. Hoyng
- Reinier O. Schlingemann
- Elon H. C. van Dijk
Institutions
- Radboud University Nijmegen (NL)
- Leiden University Medical Center (NL)
- Radboud University Medical Center (NL)
- Rotterdam Eye Hospital (NL)
- Fondation Asile des Aveugles (CH)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- Acta Ophthalmologica
- Published
- 2026-02-11
- DOI
- https://doi.org/10.1111/aos.70106
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00